166 related articles for article (PubMed ID: 9873505)
1. Novel H3 receptor antagonists. Sulfonamide homologs of histamine.
Wolin R; Connolly M; Afonso A; Hey JA; She H; Rivelli MA; Willams SM; West RE
Bioorg Med Chem Lett; 1998 Aug; 8(16):2157-62. PubMed ID: 9873505
[TBL] [Abstract][Full Text] [Related]
2. 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: the design of potent histamine H3 receptor antagonists.
Tozer MJ; Buck IM; Cooke T; Kalindjian SB; McDonald IM; Pether MJ; Steel KI
Bioorg Med Chem Lett; 1999 Nov; 9(21):3103-8. PubMed ID: 10560733
[TBL] [Abstract][Full Text] [Related]
3. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
[TBL] [Abstract][Full Text] [Related]
4. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L
Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552
[TBL] [Abstract][Full Text] [Related]
5. 4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor.
Aslanian R; Brown JE; Shih NY; wa Mutahi M; Green MJ; She S; Del Prado M; West R; Hey J
Bioorg Med Chem Lett; 1998 Aug; 8(16):2263-8. PubMed ID: 9873525
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.
De Esch IJ; Gaffar A; Menge WM; Timmerman H
Bioorg Med Chem; 1999 Dec; 7(12):3003-9. PubMed ID: 10658607
[TBL] [Abstract][Full Text] [Related]
7. Homologs of histamine as histamine H3 receptor antagonists: a new potent and selective H3 antagonist, 4(5)-(5-aminopentyl)-1H-imidazole.
Vollinga RC; Menge WM; Leurs R; Timmerman H
J Med Chem; 1995 Jan; 38(2):266-71. PubMed ID: 7830269
[TBL] [Abstract][Full Text] [Related]
8. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
Mikó T; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
Bioorg Med Chem; 2004 May; 12(10):2727-36. PubMed ID: 15110854
[TBL] [Abstract][Full Text] [Related]
9. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
[TBL] [Abstract][Full Text] [Related]
10. Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.
Stark H; Ligneau X; Sadek B; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
Bioorg Med Chem Lett; 2000 Oct; 10(20):2379-82. PubMed ID: 11055360
[TBL] [Abstract][Full Text] [Related]
11. From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H3-receptor antagonists.
Tozer MJ; Harper EA; Kalindjian SB; Pether MJ; Shankley NP; Watt GF
Bioorg Med Chem Lett; 1999 Jul; 9(13):1825-30. PubMed ID: 10406649
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
[TBL] [Abstract][Full Text] [Related]
13. Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length.
Łazewska D; Kieć-Kononowicz K; Pertz HH; Stark H; Schunack W; Elz S
Pharmazie; 2001 Dec; 56(12):927-32. PubMed ID: 11802653
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.
Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R
J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553
[TBL] [Abstract][Full Text] [Related]
15. omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists.
Tozer MJ; Buck IM; Cooke T; Kalindjian SB; Pether MJ; Steel KI
Bioorg Med Chem; 2002 Feb; 10(2):425-32. PubMed ID: 11741790
[TBL] [Abstract][Full Text] [Related]
16. Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE.
De Esch IJ; Mills JE; Perkins TD; Romeo G; Hoffmann M; Wieland K; Leurs R; Menge WM; Nederkoorn PH; Dean PM; Timmerman H
J Med Chem; 2001 May; 44(11):1666-74. PubMed ID: 11356102
[TBL] [Abstract][Full Text] [Related]
17. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.
Stark H; Sadek B; Krause M; Hüls A; Ligneau X; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
J Med Chem; 2000 Oct; 43(21):3987-94. PubMed ID: 11052804
[TBL] [Abstract][Full Text] [Related]
18. 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.
Dvorak CA; Apodaca R; Barbier AJ; Berridge CW; Wilson SJ; Boggs JD; Xiao W; Lovenberg TW; Carruthers NI
J Med Chem; 2005 Mar; 48(6):2229-38. PubMed ID: 15771465
[TBL] [Abstract][Full Text] [Related]
19. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality.
Łazewska D; Kieć-Kononowicz K; Pertz HH; Elz S; Stark H; Schunack W
Pharmazie; 2002 Dec; 57(12):791-5. PubMed ID: 12561236
[TBL] [Abstract][Full Text] [Related]
20. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
Stark H; Hüls A; Ligneau X; Purand K; Pertz H; Arrang JM; Schwartz JC; Schunack W
Arch Pharm (Weinheim); 1998 Jun; 331(6):211-8. PubMed ID: 9713254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
